Results 1 to 10 of about 2,706 (125)

HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia [PDF]

open access: yesCurrent Issues in Molecular Biology, 2023
Targeting the molecular chaperone HSP90 and the anti-apoptotic proteins MCL1 and BCL2 may be a promising novel approach in the treatment of acute myeloid leukemia (AML).
Ulrike Bacher   +2 more
exaly   +4 more sources

PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond [PDF]

open access: yesFrontiers in Pharmacology
Heat shock protein 90 (HSP90) is a pivotal molecular chaperone with multifaceted roles in cellular health and disease. Herein, we explore how HSP90 orchestrates cellular stress responses, particularly through its partnership with heat shock factor 1 (HSF-
Sameh Saber   +16 more
doaj   +2 more sources

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

open access: yesJournal of Hematology and Oncology, 2010
Background Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of anti-cancer drugs in both solid and hematologic malignancies.
Saad Z Usmani   +2 more
exaly   +3 more sources

FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia [PDF]

open access: yesCurrent Issues in Molecular Biology
Targeting the FLT3 receptor and the IL-1R associated kinase 4 as well as the anti-apoptotic proteins MCL1 and BCL2 may be a promising novel approach in the treatment of acute myeloid leukemia (AML).
Katja Seipel   +3 more
doaj   +2 more sources

Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes

open access: yesBeilstein Journal of Organic Chemistry, 2013
The attachment of biotin to a small molecule provides a powerful tool in biology. Here, we present a systematic approach to identify biotinylated analogues of the Hsp90 inhibitor PU-H71 that are capable of permeating cell membranes so as to enable the ...
Gabriela Chiosis   +2 more
exaly   +2 more sources

A Rare Paraspinal Desmoid Tumour following Instrumented Scoliosis Correction in an Adolescent

open access: yesCase Reports in Orthopedics, 2021
Desmoid tumours are benign neoplasms of myofibroblasts, often occurring after soft-tissue trauma. Rarely, desmoid tumours can occur following operative intervention, including spine surgery.
Fergus J. McCabe   +2 more
doaj   +1 more source

A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90). [PDF]

open access: yesPLoS ONE, 2013
Drug resistance, absence of an effective vaccine, and inadequate public health measures are major impediments to controlling Plasmodium falciparum malaria worldwide. The development of antimalarials to which resistance is less likely is paramount.
Dea Shahinas   +5 more
doaj   +1 more source

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. [PDF]

open access: yesPLoS ONE, 2010
The positron-emitting radionuclide (89)Zr (t(1/2) = 3.17 days) was used to prepare (89)Zr-radiolabeled trastuzumab for use as a radiotracer for characterizing HER2/neu-positive breast tumors.
Jason P Holland   +7 more
doaj   +1 more source

Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670

open access: yesCells, 2021
In Section 4.1.3 of the published paper, the authors made an incorrect and unsupported statement regarding PU-H71 and a Samus-sponsored Phase 1 clinical trial [...]
Ji Woong Kim, Yea Bin Cho, Sukmook Lee
doaj   +1 more source

Home - About - Disclaimer - Privacy